Cipla Forming a Darvas Box
Cipla is the third-largest pharma company in India (IQVIA March 2021), the third-largest[2] in the private pharma market of South Africa (IQVIA March 2021), and the largest Indian exporter to emerging markets and also amongst the most dispensed generic players in the US. Cipla has a presence in branded and unbranded generic market franchises, with leadership positions in India, South Africa, priority territories in Emerging markets, Europe, and the US, across major therapies and products categories.
Pharma as a sector had shown some bullishness in the past week , IF the sector start performing Cipla can be considered, the sector has been in a bearish mode for the past couple of months
trade only on your Due Diligence
Pharma as a sector had shown some bullishness in the past week , IF the sector start performing Cipla can be considered, the sector has been in a bearish mode for the past couple of months
trade only on your Due Diligence
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.